Breast cancer claims younger black female lives. If so, when should the screening begin?

Published Date: 26 Apr 2023

Once a woman turns 40, experts advise that she at the very least think about starting a breast cancer screening program. According to a recent study, Black women need this advice above all others.

Read Full News

Latest News

High-speed imaging tracks live brain cell activity in awake mice

A research team from the School of Engineering at The Hong Kong University of Science and Technology (HKUST) has achieved a breakthrough in brain imaging by developing the world's first technology to capture high-resolution ...

Study highlights AI limits in heart care

There are limits in applying AI to images of the heart, according to a new study from the Smidt Heart Institute at Cedars-Sinai published in the Journal of the American Society of Echocardiography.

New material may outperform current agents used in medical imaging

Scientists at Oregon State University have filed a patent on a design for a new magnetic resonance imaging contrast agent with the potential to outperform current agents while being less toxic to patients and more environmentally ...

Imaging technique maps the brain's nerve fiber labyrinth with micrometer precision

In order to understand brain diseases, neuroscientists try to untangle the intricate nerve fiber labyrinth of our brain. Before analyzing brain tissue under a microscope, it is often soaked in paraffin wax to achieve high-quality ...

New brain atlas offers unprecedented detail in MRI scans

A new AI-assisted brain atlas that can help visualize the human brain in unprecedented detail has been developed by UCL researchers, in a major step forward for neuroscience and neuroimaging.

Holographic optogenetics could enable faster brain mapping for new discoveries

Recent technological advances have opened new possibilities for neuroscience research, allowing researchers to map the brain's structure and synaptic connectivity (i.e., the junctions via which neurons communicate with each ...

Todays Updates

5 Rheumatology Headlines You Missed in December 2025 Victoria Johnson

This rheumatology month in review emphasizes new data and impactful approvals.

Q4 2025 Recap: Rheumatology News and Updates Victoria Johnson

The Q4 recap for rheumatology spotlights regulatory and clinical advances across rheumatic diseases.

Exploring Depressive Symptoms in Low-IQ Youth with Refractory Epilepsy Janelle L Wagner, PhD, Shannon Brothers, PhD, Cortney Wolfe-Christensen, PhD, Louie Pasculli

A trio of clinician authors provided insights on a recently published paper assessing youths with refractory epilepsy and ways to combat depressive symptoms.

FDA Approves Subcutaneous Copper Histidinate as First Treatment for Pediatric Menkes Disease Isabella Ciccone, MPH

The FDA approved Sentynl Therapeutics’ copper histidinate for the treatment of pediatric Menkes disease, a rare genetic neurodegenerative disorder, following an earlier complete response letter.

Rituximab Displays Long-Term Effectiveness for Relapsing MS Louie Pasculli

Annette Lenger-Gould, MD, PhD, lead for clinical and translational neuroscience at Kaiser Permanente, discusses findings and significance from a recently published trial assessing rituximab in patients with relapsing multiple sclerosis.

NeuroVoices: Nicholas Ashton, PhD, on Advances and Challenges in Alzheimer Disease Biomarkers Nicholas Ashton, PhD, Isabella Ciccone, MPH

The senior director of the Fluid Biomarker Program at Banner Health highlighted the evolving role of blood and fluid biomarkers in Alzheimer disease research and clinical practice.

High-Dose Nusinersen Gains European Commission Approval for Spinal Muscular Atrophy Louie Pasculli

The European Commission approved Biogen’s high-dose nusinersen regimen for 5q SMA, supported by DEVOTE trial data showing significantly improved motor function with a safety profile consistent with the standard-dose regimen.

Todays Updates

5 Rheumatology Headlines You Missed in December 2025 Victoria Johnson

This rheumatology month in review emphasizes new data and impactful approvals.

Q4 2025 Recap: Rheumatology News and Updates Victoria Johnson

The Q4 recap for rheumatology spotlights regulatory and clinical advances across rheumatic diseases.

Exploring Depressive Symptoms in Low-IQ Youth with Refractory Epilepsy Janelle L Wagner, PhD, Shannon Brothers, PhD, Cortney Wolfe-Christensen, PhD, Louie Pasculli

A trio of clinician authors provided insights on a recently published paper assessing youths with refractory epilepsy and ways to combat depressive symptoms.

FDA Approves Subcutaneous Copper Histidinate as First Treatment for Pediatric Menkes Disease Isabella Ciccone, MPH

The FDA approved Sentynl Therapeutics’ copper histidinate for the treatment of pediatric Menkes disease, a rare genetic neurodegenerative disorder, following an earlier complete response letter.

Rituximab Displays Long-Term Effectiveness for Relapsing MS Louie Pasculli

Annette Lenger-Gould, MD, PhD, lead for clinical and translational neuroscience at Kaiser Permanente, discusses findings and significance from a recently published trial assessing rituximab in patients with relapsing multiple sclerosis.

NeuroVoices: Nicholas Ashton, PhD, on Advances and Challenges in Alzheimer Disease Biomarkers Nicholas Ashton, PhD, Isabella Ciccone, MPH

The senior director of the Fluid Biomarker Program at Banner Health highlighted the evolving role of blood and fluid biomarkers in Alzheimer disease research and clinical practice.

High-Dose Nusinersen Gains European Commission Approval for Spinal Muscular Atrophy Louie Pasculli

The European Commission approved Biogen’s high-dose nusinersen regimen for 5q SMA, supported by DEVOTE trial data showing significantly improved motor function with a safety profile consistent with the standard-dose regimen.

Latest News

A research team from the School of Engineering at The Hong Kong University of Science and Technology (HKUST) has achieved a breakthrough in brain imaging by developing the world's first technology to capture high-resolution ...

There are limits in applying AI to images of the heart, according to a new study from the Smidt Heart Institute at Cedars-Sinai published in the Journal of the American Society of Echocardiography.

Scientists at Oregon State University have filed a patent on a design for a new magnetic resonance imaging contrast agent with the potential to outperform current agents while being less toxic to patients and more environmentally ...

In order to understand brain diseases, neuroscientists try to untangle the intricate nerve fiber labyrinth of our brain. Before analyzing brain tissue under a microscope, it is often soaked in paraffin wax to achieve high-quality ...

A new AI-assisted brain atlas that can help visualize the human brain in unprecedented detail has been developed by UCL researchers, in a major step forward for neuroscience and neuroimaging.

Recent technological advances have opened new possibilities for neuroscience research, allowing researchers to map the brain's structure and synaptic connectivity (i.e., the junctions via which neurons communicate with each ...

News All Time

Guidelines developed for postmastectomy radiation therapy

In a clinical practice guideline published online Sept. 16 in Practical Radiation Oncology, recommendations are presented for the use of postmastectomy radiation therapy (PMRT).

Adding molecular breast imaging to digital breast tomosynthesis beneficial for dense breasts

For women with dense breasts, the addition of molecular breast imaging (MBI) as a supplement to digital breast tomosynthesis (DBT) increases overall and invasive cancer detection, according to a study published online Sept. ...

CT scanners secretly waste more energy than used by a typical household, but there's a fix

Medical imaging is one of the biggest contributors of a hospital's energy use. Magnetic resonance imaging (MRI) and computed tomography (CT) are particularly carbon intensive, partly due to their need to be constantly cooled. ...

Mammograms may benefit women well into their 80s, study finds

For many older women, the question of whether to continue breast cancer screening has been uncertain. While most guidelines recommend mammograms up to age 74, advice for women 75 and older has been less clear. Now, a new ...

Turning off idling CT scanner saves 140kWh per week, enough to power an Australian home year round

CT scanners are usually left running 24/7 to be ready for patients who need emergency scans. Now researchers have conducted the first Australian study on the benefits of switching off radiology equipment when not in use.

2016 to 2023 saw decline in U.S. pediatric radiologists

The number of U.S. pediatric radiologists declined from 2016 to 2023, according to a study published online Sept. 9 in the Journal of the American College of Radiology.

Innovative imaging techniques show what happens inside bones during hip replacement surgery

Uncemented hip replacement surgery uses implants with roughened surfaces designed to allow the patient's bone to grow directly onto the implant, creating a strong, natural biological bond. Unlike cemented implants, which ...

AI effective at detecting advanced breast cancer, but misses some cases

A Korean research team has reported that artificial intelligence (AI) used in mammography missed 14% of invasive breast cancers, the type where delayed diagnosis can directly impact patient survival.

Reversible technique turns mouse scalps transparent for imaging brain development

During childhood and adolescence, our brain goes through a lot of changes. But studying those changes in juvenile mice is challenging because scientists don't have a way to repeatedly image the same animal's neural pathways ...

Dual-mode tracer could enable surgeons to see and 'hear' prostate cancer

A preclinical evaluation of a new "dual-mode" tracer agent shows promise in not only helping surgeons image and plan prostate cancer procedures, but also provide them with much more consistent and targeted guidance during ...

Imaging provides indicators for early detection of depression, paths for future prevention and treatment efforts

Novel imaging research indicates that young adults with a higher genetic risk for depression showed less brain activity in several areas when responding to rewards and punishments. The study also uncovered notable differences ...

Jul 25 2025 This Week in Cardiology

The VENTOUX study of endurance athletes, the 10,000 step myth was not busted, rate vs rhythm control for AF, and GLP1 drugs and observational studies are the topics John Mandrola, MD, discusses in this week’s podcast.

Large-scale neuroimaging data collection proves feasible in low-income communities

People are diverse, and the environments they live in may influence them differently. This broad diversity increases the need for neuroimaging studies that collect data from large communities.

S2 Episode 2: The Exercise Prescription for MS Just Got Stronger

Join Drs Anne Cross and Rob Motl as they discuss how new data and clinical insights are reshaping how exercise helps people with MS.

Body Composition Analysis in HF: Time to Replace BMI?

A recent meta-analysis prompts consideration of measurements of visceral and subcutaneous adiposity to better estimate cardiovascular risk than BMI.

AI helps radiologists spot more lesions in mammograms

Artificial intelligence (AI) improves breast cancer detection accuracy for radiologists when reading screening mammograms, helping them devote more of their attention to suspicious areas, according to a study published in ...

Recommended News For You

Coffee and tea linked to lower head and neck cancer risk

A computer-aided diagnostic system for improved detection of breast cancer.

Childhood brain tumors develop early in highly specialized nerve cells, research reveals

Un nou sistem de endoscopică imaging are capacitatea de a detecta mai mulți fluorescent tracers.

Scholastic performance is a key concern for young cancer patients, study finds

Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap

PNH With Extravascular Hemolysis Approves Factor D Inhibitor.

Recommended Articles For You

The Digital Revolution in Oncology - How Software, AI, and Data are Reshaping Cancer Care by 2025 

Unlocking the Secrets of Hemoglobin: How It Works to Keep Us Healthy 

Unlocking the Potential of Plinabulin: A New Frontier in Cancer Treatment 

The Pivotal Role of Telomerase in Breast Cancer Therapy Resistance and Treatment Strategies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In patients with advanced lung cancer, cemiplimab combined with chemotherapy extends life and enhances quality of life.

2.

Detecting pancreatic cancer through changes in body composition and metabolism

3.

Formaldehyde Causes More Cancer Than Any Other Toxic Air Pollutant

4.

In leukemia, allogeneic HCT is beneficial following primary induction failure.

5.

For Localized Prostate Cancer, HIFU Is Not Worse Than Prostatectomy.

1.

Giant Sebaceous Cyst of the Scalp Mimicking a Soft Tissue Tumor: A Case Study

2.

The Statistical Frontier of Hematology Oncology: Diagnostics, Therapies, and Future Horizons in Hematology Oncology 2025

3.

Asymptomatic Thrombocytopenia: Unraveling the Enigma of Low Platelet Counts Without Symptoms

4.

Liquid Biopsies in Hematology: A Window into the Disease

5.

A Breakthrough in Multiple Myeloma: Darzalex Delays Disease Progression by 51%

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part XI

2.

Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2

3.

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

4.

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?

5.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot